Walleye Trading LLC Fibrogen Inc Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $97,948 - $154,630	6,141 New	6,141 $114,000
Q2 2022 Aug 08, 2022	SELL	$7.94 - $12.96 $205,685 - $335,728	-25,905 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $173,520 - $242,380	14,436 Added 125.87%	25,905 $311,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $792,731 - $1.23 Million	-79,832 Reduced 87.44%	11,469 $162,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $369,248 - $966,286	36,272 Added 65.91%	91,301 $933,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $674,388 - $1.3 Million	36,316 Added 194.07%	55,029 $1.47 Million
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $92,676 - $104,195	-2,290 Reduced 10.9%	18,713 $769,000
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $248,118 - $326,278	-7,618 Reduced 26.62%	21,003 $851,000
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $596,130 - $1.18 Million	25,585 Added 842.72%	28,621 $995,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $55,211 - $72,335	1,493 Added 96.76%	3,036 $112,000
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $364,992 - $527,978	-8,129 Reduced 84.05%	1,543 $97,000
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $438,625 - $596,278	9,672 New	9,672 $447,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.